Immunologic Changes During Specific Treatment of the Atopic State

Zavázal, V; Stajner, A; S̆indelár̆, J.

doi:10.1111/j.1398-9995.1972.tb01408.x

Cited by 3 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Measurements of antibody by haemagglutination (Reisman, Wicher & Arbesman, 1969), by blocking the challenge by allergen of sensitized leucocytes (Levy c/ ai, 1971;Starr & Weinstock, 1970) or by binding of labelled allergen (Melam et ai, 1971;Zavazal & Stajner, 1970) have shown increases following therapy, but in most cases a direct correlation of titres with clinical improvement has not been possible.…”

Section: Introductionmentioning

confidence: 99%

Changes in serum antibody levels during treatment with grass pollen‐tyrosine adsorbate

Johansson¹,

Miller²,

Ovfrell³

et al. 1974

Clin Experimental Allergy

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Changes in serum antibody levels during treatment with grass pollen‐tyrosine adsorbate

Johansson¹,

Miller²,

Ovfrell³

et al. 1974

Clin Experimental Allergy

View full text Add to dashboard Cite

show abstract

Allergic Diseases of the Respiratory Tract

Hajós¹,

Hajos²

1976

Immunological Aspects of Allergy and Allergic Diseases

View full text Add to dashboard Cite

Serum Concentrations of Allergen-specific IgG Antibodies in Inhalant Allergy: Effect of Specific Immunotherapy

Ali

Ramanarayanan

Nalebuff

et al. 1983

American Journal of Clinical Pathology

View full text Add to dashboard Cite

The occurrence of antibodies belonging to IgG class of immunoglobulins with specificity for short ragweed and Bermuda grass in the sera of nonatopic subjects and patients with inhalant allergy (at the time of initial diagnosis, following specific immunotherapy was investigated with an enzyme immunoassay. The intra-assay and inter-assay coefficients of variation for this assay ranged from 1.74%-4.62% and 3.18%-9.12%, respectively. IgG antibodies were found in the sera of the majority of nonatopic and all of atopic subjects. The differences in the concentration of these antibodies between these three groups were statistically significant (P less than 0.001). Specific immunotherapy resulted in a rise in the serum levels of allergen-specific IgG antibodies and, following an initial period of modest increase, a decrease in the level of allergen-specific IgE antibodies. Specific IgG response correlated with both the cumulative antigen dose and the clinical benefit that accrued from specific immunotherapy (P less than 0.001). The increase in the serum concentration of specific IgG was most pronounced in patients with high RAST scores at the time of initial diagnosis (P less than 0.001). The concentrations of short-ragweed specific IgG antibodies assayed with multiple samples in three patients with ragweed hay fever appeared not to be affected by the short-ragweed season to any significant degree. We conclude that direct enzyme immunoassay for allergen-specific IgE and IgG antibodies are useful in vitro monitors of immunologic responses to specific immunotherapy for inhalant allergy.

show abstract

Immunologic Changes During Specific Treatment of the Atopic State

Cited by 3 publications

References 16 publications

Changes in serum antibody levels during treatment with grass pollen‐tyrosine adsorbate

Changes in serum antibody levels during treatment with grass pollen‐tyrosine adsorbate

Allergic Diseases of the Respiratory Tract

Serum Concentrations of Allergen-specific IgG Antibodies in Inhalant Allergy: Effect of Specific Immunotherapy

Contact Info

Product

Resources

About